Amanda C Foks, et al. showed that anti-Tim-3 antibody treatment promoted plaque formation in atherosclerosis model, increased lesional percentages of macrophages and CD4(+) T cells and enhanced their activation (Foks et al., 2013). Here, HAVCR2 is linked to atherosclerosis.